Bifidobacterium breve BBr60 improves obesity via the gut microbiotashort-chain fatty acidIL-27/GLP-1 axis: Evidence from a randomized, double-blind, placebo-controlled trial
(September 2023) Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis (September 2023) As Semaglutides Popularity Soars, Rare but Serious Adverse Effects Are Emerging (November 2023) Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the UglyBenefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying (January 2024) Diabetic gastroparesis: a disease for which long-term therapeutic benefits are difficult to obtain (May 2024) Other Possible Side Effects of Zepbound Explored Tirzepatide, the active ingredient in Zepbound, belongs to a class of drugs called GLP-1 agonists
-GLP-1 Therapy for Men Chicago A Smarter Approach to Mens Weight Loss Men today face unique challenges when it comes to weight loss
Changes based on weight loss: If a person is losing weight too quickly, the dose can be reduced
Call or Text: 312.312.7873 Book Appointment Online: A consultation helps determine whether prescription GLP-1 therapy is right for you and explains the difference between prescription GLP-1 vs compounded weight loss injections in detail
Haufe S, Kaminski J, Utz W, Haas V, Mhler A, Daniels MA, et al